Gainesville, FL, United States of America

Nasser Chegini


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nasser Chegini: Innovator in Reproductive Health

Introduction

Nasser Chegini is a notable inventor based in Gainesville, FL (US), recognized for his contributions to the field of reproductive health. With a total of 2 patents, his work focuses on innovative methods for detecting and treating reproductive tract disorders.

Latest Patents

Chegini's latest patents include groundbreaking methods for detecting and treating female reproductive tract disorders. His first patent addresses the differential expression of IL-13 and IL-15 in biological samples from subjects suffering from reproductive tract disorders compared to healthy individuals. This method involves analyzing the expression of these cytokines in biological samples to correlate their levels with the presence of reproductive tract disorders. Additionally, he has developed methods for preventing adhesion formation through the administration of therapeutic formulations that include antibodies to TIMP-1 or TIMP-1 antisense oligonucleotides. These formulations can be optimized with suitable carriers, such as a hyaluronic acid matrix, to enhance their effectiveness.

Career Highlights

Throughout his career, Nasser Chegini has worked with esteemed institutions, including the University of Florida Research Foundation and Wayne State University. His research has significantly advanced the understanding and treatment of reproductive health issues.

Collaborations

Some of his notable coworkers include James W. Burns and Michael P. Diamond, who have contributed to his research endeavors.

Conclusion

Nasser Chegini's innovative work in reproductive health has led to significant advancements in the detection and treatment of reproductive tract disorders. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…